Skip to main content
SpringerLink
Log in

Strategic investment in preventive health care: Quantitative modelling for programme selection and resource allocation

  • Invited Review
  • Published:
Operations-Research-Spektrum Aims and scope Submit manuscript

Abstract

This paper reviews contemporary quantitative approaches to programme selection and resource allocation in preventive health care. For this purpose it is first shown that preventive health programmes are strategic investments. Then we give reasons why cost-effectiveness analysis is our preferred general frame of reference. Within this framework several representative quantitative policy models are discussed next. In the field of chronic illnesses we focus on the prevention of cancer and cardiovascular diseases, the main causes of death and disability in the industrialized countries. Examples from the field of contagious diseases relate to tuberculosis and malaria control, and to the spread of the Acquired Immune Deficiency Syndrome (AIDS). Finally, we present the case of innovation in preventive health technology from a strategic investment angle.

Zusammenfassung

Diese Arbeit gibt einen Überblick über quantitative Programmauswahl- und Ressourcenallokationsmodelle im Bereich der präventiven Gesundheitsversorgung. Zunächst wird gezeigt, daß präventive Gesundheitsprogramme strategische Investitionen darstellen. Anschließend wird begründet, weshalb sich die Kosten-Wirksamkeits-Analyse als allgemeiner Bezugsrahmen anbietet. Innerhalb dieses Rahmens werden dann aus unterschiedlichen Bereichen repräsentative quantitative strategische Modelle erörtert. Im Bereich nichtübertragbarer Erkrankungen liegt der Schwerpunkt bei Krebs und Herz-Kreislauf-Krankheiten, den Hauptursachen für Tod und Gesundheitsbeeinträchtigung in den Industrieländern. Hinsichtlich übertragbarer Krankheiten konzentrieren wir uns auf Tuberkulose, Malaria und AIDS. Ein vorgelagertes Spezialproblem ist die gesundheitsökonomische Bewertung neuer Präventionstechnologien. Die hier verfügbaren quantitativen Modellierungsansätze werden ebenfalls angesprochen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahmed R (1978) On optimal resource allocation in community hypertension programs. Mgmt Sci 24:1749–1752

    Article  Google Scholar 

  • Arrow K (1963) Uncertainty and the welfare economics of medical care. Am Econ Rev 53:941–973

    Google Scholar 

  • A Who Meeting (1986) The use of quantitative methods in planning national cancer control programmes. Bull Wrld Hlth Org 64(5):683–693

    Google Scholar 

  • Bailey NTJ (1975) The mathematical theory of infectious diseases and its application. Hafner-Press, New York

    Google Scholar 

  • Baker S, Heidenberger K (1989) Choosing sample sizes to maximize health benefits subject to a constraint on total trial costs. Med Dec Making 9:14–25

    Article  Google Scholar 

  • Barlow R (1967) The economic effects of malaria eradication. Am Econ Rev 57 (App):130–148

    Google Scholar 

  • Bierman H, Smidt S (1993) The capital budgeting decision: economic analysis of investment projects. 8th edn. Macmillan, New York

    Google Scholar 

  • Blum H (1981) Planning for health: generics for the eighties. 2nd edn. Human Sciences Press, New York

    Google Scholar 

  • Boyd A, Davies LA, Bagust A (1989) Modelling the implications for hospital services of cervical cytology screening: a case history. J Opl Res Soc 40:529–537

    Article  Google Scholar 

  • Brandeau ML, Lee HL, Owens DK, Sox CH, Wächter RM (1991) A policy model of human immunodeficiency virus screening and intervention. Interfaces 21(3):5–25

    Article  Google Scholar 

  • Brandeau ML, Owens DK, Sox CH, Wachter RM (1993) Screening women of childbearing age for human immunodeficiency virus: a model-based policy analysis. Mgmt Sci 39:72–92

    Article  Google Scholar 

  • Brooks RG (1986) The development and construction of health status measures. IHE report 1986: 4. The Swedish Institute for Health Economics, Lund

    Google Scholar 

  • Brooks RG (1988) Scaling in health status measurement: an outline guide and commentary. IHE report 1988: 4. The Swedish Institute for Health Economics, Lund

    Google Scholar 

  • Bross IDJ, Blumenson LE (1968) Statistical testing of a deep mathematical model for human breast cancer. J Chron Dis 21:493–506

    Article  Google Scholar 

  • Chorba RW, Sanders JL (1971) Planning models for tuberculosis control. Hlth Serv Res 6(2):144–164

    Google Scholar 

  • Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, London

    Google Scholar 

  • Creese A (1983) The economic evaluation of immunization programmes. In: Lee K, Mills A (eds.) The economics of health in developing countries. Oxford University Press, Oxford

    Google Scholar 

  • Cretin S (1977) Cost-benefit analysis of treatment and prevention of myocardial infarction. Hlth Serv Res 12(2):174–189

    Google Scholar 

  • Crystal R, Brewster A (1966) Cost-benefit and cost-effectiveness analysis in the health field: an introduction. Inquiry 3:3–13

    Google Scholar 

  • Culyer AJ (ed.) (1983) Health indicators. Martin Robertson, London

    Google Scholar 

  • Detsky AS (1985) Using economic analysis to determine the resource consequences of choices made in planning clinical trials. J Chron Dis 38:753–765

    Article  Google Scholar 

  • Dorfman R (ed) (1965) Measuring benefits of government investments. The Brookings Institution, Washington, D.C.

    Google Scholar 

  • Drummond MF (1980) Principles of economic appraisal in health care. Oxford University Press, Oxford

    Google Scholar 

  • Drummond MF (1989) Output measurement for resource allocation decisions in health care. Oxford Rev Econ Policy 5(1):59–74

    Article  Google Scholar 

  • Drummond MF, Stoddart GL, Torrance GW (1987) Methods of the economic evaluation of health care programmes. Oxford University Press, Oxford

    Google Scholar 

  • Drummond MF, Heyse J, Cook J, McGuire A (1993) Selection of end points in economic evaluations of coronary-heart-disease interventions. Med Dec Making 13:184–190

    Article  Google Scholar 

  • Dunlop D (1975) Benefit-cost analysis: a review of its applicability in policy analysis for delivering health services. Soc Sci Med 9:133–139

    Article  Google Scholar 

  • Eddy DM (1980) Screening for cancer: theory, analysis and design. Prentice Hall, Englewood Cliffs, NJ

    Google Scholar 

  • Eddy DM (1986) A computer-based model for designing cancer control strategies. Nat Canc Inst Monogr 2:75–82

    Google Scholar 

  • Eddy DM, Shwartz M (1982) Mathematical models in screening. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. Saunders, Philadelphia, PA

    Google Scholar 

  • Farrington CP (1989) Optimal screening policies for Hepatitis A. J Opl Res Soc 40:355–359

    Article  Google Scholar 

  • Feldstein MS, Piot MA, Sundaresan TK (1973) Resource allocation model for public health planning: a case study of tuberculosis control. Bull Wrld Hlth Organ 48 (Suppl.):1–110

    Google Scholar 

  • Fineberg H (1983) Impact of technological investment on the cost of the health care system. J Neuroradiol 10:199–204

    Google Scholar 

  • Fineberg HV, Hiat HH (1979) Evaluation of medical practices: the case of technology assessment. N Engl J Med 301:1086–1091

    Article  Google Scholar 

  • Fuchs V (1979) The economics of health in a post-industrial society. The Public Interest (Summer):3–20

    Google Scholar 

  • Fuchs V (1980) What is CBA/CEA, and why are they doing this to us. N Engl J Med 303:937–938

    Article  Google Scholar 

  • Fuchs V (1986) The health economy. Harvard University Press, Cambridge, MA

    Google Scholar 

  • Gail MH, Preston D, Piantadosi S (1989) Disease prevention models of voluntary confidential screening for human immunodeficiency virus (HIV). Stat Med 8:59–81

    Article  Google Scholar 

  • Ganiats TG (1994) Discounting in cost-effectiveness research. Med Dec Making 14:298–300

    Article  Google Scholar 

  • Gelijns AC, Halm EA (eds) (1991) Medical innovation at the crossroads, Vol 2: The changing economics of medical technology. National Academy Press, Washington D.C.

    Google Scholar 

  • Goldman TA (ed) (1967) Cost-effectiveness analysis: new approaches in decision making. Washington Operations Research Council (Frederic A. Praeger), New York

    Google Scholar 

  • Habbema JDF, Lubbe JTN, Oortmarssen GJ van, Maas PJ van der (1987) A simulation approach to cost-effectiveness and cost-benefit calculations of screening for the early detection of disease. Eur J Opl Res 29:159–166

    Article  Google Scholar 

  • Hall NJ, Hershey JC, Kessler L, Stotts RC (1992) A model for making project funding decisions at the National Cancer Institute. Ops Res 40:1040–1052

    Article  Google Scholar 

  • Hartunian NS, Smart CN, Thompson MS (1980) The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. Am J Publ Hlth 70:1249–1260

    Article  Google Scholar 

  • Heidenberger K (1982a) Gruppenspezifische Auswahl von Diagnosestrategien im Bereich der Hypertoniefrüherkennung. Ein Modell der linearen 0/1-Programmierung. OR Spektrum 4:91–104

    Article  Google Scholar 

  • Heidenberger K (1982b) Hypertension policy analysis allowing for group-specific diagnostic strategies. Methods Inf Med 21:197–204

    Google Scholar 

  • Heidenberger K (1983) Strategische Analyse der sekundären Hypertonieprävention. Springer, Berlin

    Book  Google Scholar 

  • Heidenberger K (1988a) Strategische Planung horizontal und vertikal differenzierter Gesundheitsprogramme. OR Spektrum 4:221–235

    Article  Google Scholar 

  • Heidenberger K (1988b) Optimal resource allocation in horizontally and vertically disaggregated health programs. In: Fandel G (ed) Management problems in health care. Springer, Berlin

    Google Scholar 

  • Heidenberger K (1990a) Dynamische Gesundheitsprogrammplanung: Ein strategisches Modell der Nichtlinearen Programmierung. OR Spektrum 12:163–172

    Article  Google Scholar 

  • Heidenberger K (1990b) Quantitative Modelle für das Strategische Management. Springer, Berlin

    Book  Google Scholar 

  • Heidenberger K (1992) Strategic decision support in preventive health care. Soc-Econ Plann Sci 26:129–146

    Article  Google Scholar 

  • Heidenberger K (1994) Health related product innovation in life insurance: a micro-simulation based decision support system. Paper presented at the 13th European and 36th National Congress on Operational Research, Glasgow, July 19–22

  • Heidenberger K, Flessa S (1991) AIDS-Dynamik in Tansania: eine strategische Simulation. Öff Gesundh Wes 53:241–249

    Google Scholar 

  • Heidenberger K, Flessa S (1993) A system dynamics model for AIDS policy support in Tanzania. Eur J Opl Res 70:167–176

    Article  Google Scholar 

  • Hethcote HW, Yorke JA (1984) Gonorrhea transition dynamics and control. Springer, New York

    Book  Google Scholar 

  • Homer JB, St. Clair CLS (1991) A model of HIV transmission through needle sharing. Interfaces 21(3):26–49

    Article  Google Scholar 

  • Houshyar A, Al-Khayyal (1990) A mathematical model for scheduling screening tests for progressive diseases. Soc-Econ Plann Sci 24:187–197

    Article  Google Scholar 

  • Iglehart JK (1982) Health care and American business. N Engl J Med 306:120–124

    Article  Google Scholar 

  • Kamlet MS (1992) The comparative benefits modeling project: a framework for cost-utility analysis of government health care programs. U.S. Government Printing Office, Washington D.C.

    Google Scholar 

  • Kannel W, McGee D, Gordon T (1976) A general cardiovascular risk profile: The Framingham study. Am J Cardiol 38:46–51

    Article  Google Scholar 

  • Kaplan EH (1989) What are the risks of risky sex? Modeling the AIDS epidemic. Ops Res 37:198–209

    Article  Google Scholar 

  • Kaplan EH, Brandeau ML (1994) Modeling the AIDS epidemic: planning, policy, and prediction. Raven Press, New York

    Google Scholar 

  • Keeler EB, Cretin S (1983) Discounting of life-saving and other nonmonetary outcomes. Mgmt Sci 29:300–306

    Article  Google Scholar 

  • Kermack WO, McKendrick AG (1927, 1932, 1933) Contributions to the mathematical theory of epidemics. Proc R Soc 115:700–721; 138:55–83; 141:94–122

    Article  Google Scholar 

  • Kessler L, Taylor P (1989) Prevention trials (Editorial). Med Dec Making 9:1–2

    Article  Google Scholar 

  • Klarman HE (1965) Syphilis control programs. In: Dorfman R (ed.) Measuring benefits of government investments. The Brooking Institution, Washington, D.C.

    Google Scholar 

  • Klarman HE (1974) Application of cost-benefit analysis to the health services and the special case of technological innovation. Int J Hlth Serv 4:325–352

    Article  Google Scholar 

  • Klarman HE (1982) The road to cost-effectiveness analysis. Milbank Meml Fund Q 60:585–603

    Article  Google Scholar 

  • Knox EG (1973) A simulation system for screening procedures. Problems and progress in medical care 9:19–55

    Google Scholar 

  • Kristein MM (1977) Economic issues in prevention. Prev Med 6:252–264

    Article  Google Scholar 

  • Kristein MM (1980) The economics of screening for colo-rectal cancer. Soc Sci Med 14C:275–284

    Google Scholar 

  • Kristein MM (1983) Using cost-effectiveness and cost-benefit analysis for health care policy making. Adv Hlth Econ Hlth Serv Res 4:199–224

    Google Scholar 

  • Kristein MM, Arnold CB, Wynder EL (1977) Health economics and preventive care. Science 195:457–462

    Article  Google Scholar 

  • Lairson DR, Swint JM (1988) Economic considerations in technology assessment: the case of genetic disease. Hlth Policy 9:309–315

    Article  Google Scholar 

  • Lee HL, Pierskalla WP (1988) Mass screening models for contagious diseases with no latent period. Ops Res 36:917–928

    Article  Google Scholar 

  • Lipscomb J (1989) Time preferences for health in cost-effectiveness analysis. Med Care 27:233–253

    Article  Google Scholar 

  • Manton KG (1985) Procedures for evaluating the population-level impact of primary prevention: a review of models for risk assessment forecasting on impact determination. A report prepared for the World Health Organization. Division of Noncommunicable Diseases. Center for Demographic Studies, Duke University, Durham, NC

    Google Scholar 

  • Margolis J (1977) Shawdow prices for incorrect or nonexistent market values. In: Haveman RH, Margolis J (eds.) Public expenditure and policy analysis, 2nd edn. Rand McNally, Chicago

    Google Scholar 

  • McKinlay JB, McKinlay SM (1977) The questionable contribution of medical measures to the decline of mortality in the United States in the twentieth century. Milbank Meml Fund Q 55:405–428

    Article  Google Scholar 

  • McNeil BJ, Dudley RA, Hoop B, Metz C, Thompson M, Adelstein SJ (1981) A cost-effectiveness analysis of screening for hepatitis B surface antigen in India. Med Dec Making 1:345–359

    Article  Google Scholar 

  • Milsum JH (1989) Determining optimal screening policies, using decision trees and spreadsheets. Comp Biol Med 19:231–243

    Article  Google Scholar 

  • Milsum JH (1991) On the optimization of cholesterol screening. Methods Inf Med 30:36–43

    Google Scholar 

  • Moses S, Plummer FA, Ngugi EN, Nagelkerke NJD, Anzada AO, Ndinya-Acjola JO (1991) Controlling HIV in Africa: effectiveness and cost of an intervention in high-frequency STD transmitter groups. AIDS 5:407–411

    Article  Google Scholar 

  • Moskowitz H, Plante R, Tsai HT (1993) A multistage screening model for evaluation and control of misclassification error in the detection of hypertension. Mgmt Sci 39:307–321

    Article  Google Scholar 

  • Mosteller F, Weinstein MC (1985) Toward evaluating the cost-effectiveness of medical and social experiments. In: Hausman JA, Wise DA (eds.) Social experimentation. University of Chicago Press, Chicago

    Google Scholar 

  • Mushkin S (1958) Toward a definition of health economics. Publ Hlth Rep 73:785–793

    Article  Google Scholar 

  • Mushkin SJ (1962) Health as an investment. J Polit Econ 70(Oct. Suppl.):129–157

    Article  Google Scholar 

  • Neuhauser D, Stason WB (1980) Cost-effective clinical decision making. In: Carels EJ, Neuhauser D, Stason WB (eds.) The physician and cost control. Oelgeschlager, Gunn & Hain, Cambridge, MA

    Google Scholar 

  • Nichols AL, Weinstein MC (1978) Optimal resource allocation in community hypertension programs. Mgmt Sci 24:1526–1537

    Article  Google Scholar 

  • O'Brien B, Viramontes JL (1994) Willingness to pay: a valid and reliable measure of health state preference? Med Dec Making 14:289–297

    Article  Google Scholar 

  • Office of Technology Assessment, U.S. Congress (1980) The implications of cost-effectiveness analysis of medical technology. Background paper no. 1: Methodological issues and literature review. U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  • Oortmarssen GJ van, Habbema JDF, Lubbe JTN, Jong GA de, Maas PJ van der (1981) Predicting the effects of mass screening for disease — a simulation approach. Eur J Opl Res 6:399–409

    Article  Google Scholar 

  • Özekici S, Pliska SR (1991) Optimal scheduling of inspections: a delayed Markov model with false positives and negatives. Ops Res 39:261–273

    Article  Google Scholar 

  • Packer AH (1968) Applying cost-effectiveness concepts to the community health system. Ops Res 16:227–253

    Article  Google Scholar 

  • Parker BR (1978) Quantitative decision techniques for the health/public sector: an analysis and classification of resources. J Hlth Politics Policy Law 3:388–429

    Article  Google Scholar 

  • Parker BR (1983) A program selection/resource allocation model for control of malaria and related parasitic diseases. Comput Ops Res 10:375–389

    Article  Google Scholar 

  • Parker BR (1990) In quest of useful health care decision models for developing countries. Eur J Opl Res 49:279–288

    Article  Google Scholar 

  • Petersen CC (1981 a) Cost of cardiovascular disease and planning for future directions of the U.S. Air Force HEART program. Prev Med 10:277–286

    Article  Google Scholar 

  • Petersen CC (1981b) Manpower modeling in cost-effectiveness studies of USAF program to reduce the incidence of heart disease. Nav Res Logist Q 28:157–168

    Article  Google Scholar 

  • Petersen CC (1982) Simulation of alternative designs of a cardiovascular risk reduction program for the U.S. Air Force. J Med Sys 6(2):149–164

    Article  Google Scholar 

  • Prest AR, Turvey R (1965) Cost-benefit analysis: a survey. Econ J 75:683–735

    Article  Google Scholar 

  • Prorok PV (1984) Evaluation of screening programs for the early detection of cancer. In: Cornell RG (ed) statistical methods for cancer studies. Marcel Dekker, New York

    Google Scholar 

  • Ravindran A, Sadagopan A, Petersen CC, Hatsell CP (1980) Using simulation in cardiovascular disease control. Simulation (July):13–20

    Article  Google Scholar 

  • Redelmeier DA, Heller DN (1993) Time preference in medical decision making and cost-effectiveness analysis. Med Dec Making 13:212–217

    Article  Google Scholar 

  • Redelmeier DA, Heller DN, Weinstein MC (1994) Time preference in medical economics: science or religion? Med Dec Making 14:301–303

    Article  Google Scholar 

  • Reilly CH, Petersen CC (1988) Implementation planning for a USAF-wide cardiovascular-risk-reduction program. IIE Transact 20:97–102

    Article  Google Scholar 

  • Reisman A, Kirschnick F (1994) The devolution of OR/MS: implications from a statistical content analysis of three flagship journals. Ops Res 42:577–588

    Article  Google Scholar 

  • ReVelle C, Lynn WR, Feldman F (1967) Mathematical models for the economic allocation of tuberculosis control activities in developing nations. Am Rev Resp Dis 96:893–909

    Google Scholar 

  • ReVelle C, Feldman F, Lynn W (1969) An optimization model of tuberculosis epidemiology. Mgmt Sci 16:B190-B211

    Article  Google Scholar 

  • Rice DP, Hodgson TA, Kopstein AN (1985) The economic cost of illness: a replication and update. Hlth Care Finan Rev 7:61–80

    Google Scholar 

  • Rogers PJ, Eaton EK, Bruhm JG (1981) Is health promotion costeffective? Prev Med 10:324–339

    Article  Google Scholar 

  • Rowley JT, Anderson RM (1994) Modelling the impact and cost-effectiveness of HIV prevention efforts. AIDS 8:539–548

    Article  Google Scholar 

  • Russell LB (1984) The economics of prevention. Hlth Policy 4:85–100

    Article  Google Scholar 

  • Russell LB (1986) Is prevention better than cure. The Brookings Institution, Washington, D.C.

    Google Scholar 

  • Russell LB (1987) The economics of prevention: reply to Roy Shepard. Hlth Policy 7:57–59

    Article  Google Scholar 

  • Rutten FFH, Drummond MF (1994) Making decisions about health technologies: a cost-effectiveness perspective. Institute for Medical Technology Assessment, University of York, York, UK

    Google Scholar 

  • Schieber GJ, Poullier JP, Greenwald LM (1993) Health spending, delivery and outcomes in OECD countries. Hlth Affairs 12(2):120–129

    Article  Google Scholar 

  • Schwartz JS, Kinosian B, Pierskalla WP, Lee HL (1990) Strategies for screening blood for human immunodeficiency virus antibody. J Am Med Assoc 264:1704–1710

    Article  Google Scholar 

  • Shepard DS, Thompson MS (1979) First principles of cost-effectiveness analysis in health. Publ Hlth Rep 94:535–543

    Google Scholar 

  • Shepard DS, Zeckhauser RJ (1984) Survival versus consumption. Mgmt Sci 30:423–439

    Article  Google Scholar 

  • Shepard RJ (1987) The economics of prevention: a critique. Hlth Policy 7:49–56

    Article  Google Scholar 

  • Shwartz M (1978) A mathematical model used to analyse breast cancer screening strategies. Ops Res 26:937–955

    Article  Google Scholar 

  • Shwartz M (1992) Validation of a model of breast cancer screening: an outlier observation suggests the value of breast self examination. Med Dec Making 12:222–228

    Article  Google Scholar 

  • Shwartz M, Plough Al (1984) Models to aid in planning cancer screening programs. In: Cornell RG (ed) Statistical methods for cancer studies. Marcel Dekker, New York

    Google Scholar 

  • Smith WF (1968) Cost-effectiveness and cost-benefit analysis for public health programs. Publ Hlth Rep 83:899–906

    Article  Google Scholar 

  • Sondik EJ, Stahr W, Haines CM, Jones HH, Renich P (1979) Interactive hypertension treatment model for the National High Blood Pressure Education Program. Paper presented at the National Conference on High Blood Pressure. Washington, D.C., April (typescript)

  • Thompson MS (1983) Health versus money: value judgements in the perspective of decision analysis. Med Dec Making 3:285–297

    Article  Google Scholar 

  • Thompson MS, Fortess EE (1980) Cost-effectiveness analysis in health program evaluation. Eval Rev 4:549–568

    Article  Google Scholar 

  • Tormans G, Damme P van, Carrin G, Clara R, Eylenbosch W (1993) Cost-effectiveness analysis of prenatal screening and vaccination against Hepatitis B virus — the case of Belgium. Soc Sci Med 37:173–181

    Article  Google Scholar 

  • Torrance GW (1986) Measurement of health state utilities for economic appraisal: a review. J Hlth Econ 4:1–130

    Article  Google Scholar 

  • Treasury HM (1982) Investment appraisal in the public sector. Her Majesty's Stationary Office, London

    Google Scholar 

  • Tsevat J (1992) Impact and cost-effectiveness of smoking interventions. Am J Med 93(1 A):43S-47S

    Article  Google Scholar 

  • Tsodikov AD, Yakovlev AY (1991) On the optimal policies of cancer screening. Math Biosci 107:21–45

    Article  Google Scholar 

  • Urban N, Baker M (1989) The women's health trial as an investment. Med Dec Making 9:59–64

    Article  Google Scholar 

  • Voelker JA, Pierskalla WP (1980) Test selection for a mass screening program. Nav Res Logist Q 27:43–56

    Article  Google Scholar 

  • Wagner G, Tautu D, Wolber U (1981) Screening for cancer: publications 1971–1980. Methods Inf Med 20:223–251

    Google Scholar 

  • Walker A, Whynes DK (1992) Filtering strategies in mass population screening for colorectal cancer: an economic evaluation. Med Dec Making 12:2–7

    Article  Google Scholar 

  • Warner KE (1979) The economic implications of preventive health care. Soc Sci Med 13C:227–237

    Google Scholar 

  • Warner KE, Luce BR (1982) Cost-benefit and cost-effectiveness analysis in health care: principles, practice and potential. Health Administration Press, Ann Arbor, MI.

    Google Scholar 

  • Weinstein MC (1981) Economic assessment of medical practices and technologies. Med Dec Making 1:309–330

    Article  Google Scholar 

  • Weinstein MC, Stason WB (1977) Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296:716–721

    Article  Google Scholar 

  • Weinstein MC, Coxson PG, Williams LW, Pas TM, Stason WB, Goldman L (1987) Forecasting coronary heart disease incidence, mortality and cost: the coronary heart disease policy model. Am J Publ Hlth 77:1417–1426

    Article  Google Scholar 

  • Weisbrod BA (1971) Costs and benefits of medical research: a case study of poliomyelitis. J Polit Econ 79:527–544

    Article  Google Scholar 

  • Weisbrod BA, Huston JHC (1983) Benefits and costs of human vaccines in developed countries: an evaluative survey. Center for Health Economics and Law, Department of Economics, University of Wisconsin-Madison, Discussion Paper # 210

  • Woodbury MA, Manton KG, Stallard E (1981) Longitudinal models for chronic disease risk: an evaluation of logistic multiple regression and alternatives. Int J Epidem 10(2):187–197

    Article  Google Scholar 

  • Yu SZ, Miller AB, Sherman GJ (1982) Optimizing the age, number of tests and test interval for cervical cancer screening in Canada: J Epid Comm Hlth 3:1–10

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lehrstuhl für Innovations- und Technologiemanagement, Institut für Betriebswirtschaftslehre, Universität Wien, Brünner Strasse 72, A-1210, Wien, Austria

    Kurt Heidenberger

Authors
  1. Kurt Heidenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heidenberger, K. Strategic investment in preventive health care: Quantitative modelling for programme selection and resource allocation. OR Spektrum 18, 1–14 (1996). https://doi.org/10.1007/BF01539875

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01539875

Key words

Schlüsselwörter

Search

Navigation